Nurix Therapeutics, Inc.

NRIX · NASDAQ
Analyze with AI
11/30/2024
11/30/2023
11/30/2022
11/30/2021
Assets
Cash & Equivalents$109,997$54,627$64,474$80,506
Short-Term Investments$499,586$233,281$244,667$215,214
Receivables$1,500$800$1,100$6,204
Inventory$0$0-$1,100$0
Other Curr. Assets$8,304$6,795$9,308$9,194
Total Curr. Assets$619,387$295,503$318,449$311,118
Property Plant & Equip (Net)$45,896$47,950$29,508$25,345
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$7,421$63,879$137,475
Tax Assets$0$0$0$0
Other NC Assets$4,060$4,724$4,923$3,119
Total NC Assets$49,956$60,095$98,310$165,653
Other Assets$0$0$0$0
Total Assets$669,343$355,598$416,759$476,771
Liabilities
Payables$11,482$6,401$5,064$6,650
Short-Term Debt$8,014$7,489$5,530$3,847
Tax Payable$1,237$30$85$75
Deferred Revenue$38,364$48,098$37,633$41,212
Other Curr. Liab.$36,757$24,940$22,301$14,520
Total Curr. Liab.$95,854$86,958$70,655$66,258
LT Debt$20,289$23,125$6,434$9,189
Deferred Rev, NC$26,207$45,022$35,974$59,022
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$46,496$68,147$42,408$68,211
Other Liabilities$0$0$0$0
Cap. Leases$28,303$23,125$6,434$9,189
Total Liabilities$142,350$155,105$113,063$134,469
Equity
Pref Stock$0$0$0$0
Common Stock$76$49$47$45
Retained Earnings-$738,769-$545,200-$401,252-$220,892
AOCI$150-$655-$4,319-$608
Other Equity$1,265,536$746,299$709,220$563,757
Total Equity$526,993$200,493$303,696$342,302
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$669,343$355,598$416,759$476,771
Net Debt-$81,694-$24,013-$52,510-$67,470